Fig. 2From: Therapeutic effects of intranasal tocotrienol-rich fraction on rhinitis symptoms in platelet-activating factor induced allergic rhinitisThe average severity scores of AR in Control, PAF-induced AR and PAF-induced AR with TRF treatment groups. Data are representative of mean ± standard error (n = 19); ****p < 0.0001. AR, Allergic rhinitis; PAF, Platelet-activating factor; TRF, Tocotrienol-rich fractionBack to article page